GlassScriptPhysician profile
Vinit R Lal
NPI 1801850599
$15,701.74
in general payments reported to CMS, 2019-2025
48 companies · $2,903 in 2025
The $2,903 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,858 · 2020: $1,026 · 2021: $1,516 · 2022: $1,481 · 2023: $3,557 · 2024: $1,362 · 2025: $2,903.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,850 · Travel and Lodging: $2,972.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,849.78 |
| Travel and Lodging | $2,971.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $3,214.56 | 2019-2023 | Indigo System |
| Abbott Laboratories | $3,206.70 | 2019-2025 | Optis, Jot Dx, Coroflow |
| Ge Healthcare | $1,364.35 | 2019-2025 | |
| Cvrx, INC. | $571.23 | 2024-2025 | Barostim Neo System |
| Novartis Pharmaceuticals Corporation | $542.34 | 2019-2024 | |
| Medtronic Vascular, INC. | $541.84 | 2019-2020 | |
| Shockwave Medical, INC | $536.39 | 2019-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Merck Sharp & Dohme LLC | $442.82 | 2021-2024 | Verquvo |
| E.R. Squibb & Sons, L.L.C. | $371.11 | 2019-2025 | Eliquis, Camzyos |
| Cardiovascular Systems INC. | $348.51 | 2019-2023 | Diamondback Coronary |
| Boston Scientific Corporation | $345.44 | 2020-2025 | Watchman Access System, Eluvia, Bodyguardian |
| Medtronic, INC. | $332.06 | 2022-2024 | Onyx Frontier |
| Pfizer INC. | $316.36 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $273.84 | 2020-2025 | Lifevest |
| Amgen INC. | $266.84 | 2019-2024 | Repatha |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $257.30 | 2021-2024 | Impella |
| Janssen Pharmaceuticals, INC | $254.92 | 2019-2024 | Xarelto |
| Edwards Lifesciences Corporation | $241.32 | 2019-2024 | Sapien 3 Ultra Resilia |
| Artivion, INC. | $237.13 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $215.87 | 2019-2024 | |
| Chiesi USA, INC. | $215.34 | 2019-2021 | |
| Siemens Medical Solutions USA, INC. | $160.40 | 2023 | Artis One |
| Scpharmaceuticals INC. | $150.73 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $135.20 | 2019-2024 | Farxiga |
| Philips North America LLC | $127.53 | 2023-2025 | Azurion 5 M20 |
| Baxter Healthcare | $123.12 | 2022 | |
| Biotronik INC. | $114.88 | 2019-2022 | |
| Acist Medical Systems, INC. | $79.86 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $75.22 | 2019-2023 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $70.85 | 2021-2025 | |
| Cleerly, INC. | $60.70 | 2024 | Cleerly Labs, Cleerly Ischemia |
| Biosense Webster, INC. | $59.12 | 2023-2025 | Carto 3 |
| Novo Nordisk INC | $51.65 | 2025 | Wegovy |
| Lexicon Pharmaceuticals, INC. | $45.07 | 2023-2024 | Inpefa |
| Angiodynamics, INC. | $36.15 | 2022-2023 | Auryon Laser System 100-120 Vac |
| Bardy Diagnostics, INC. | $35.00 | 2019-2020 | |
| Kiniksa Pharmaceuticals, LTD. | $32.14 | 2021 | |
| Itamar Medical INC | $32.09 | 2022 | |
| Esperion Therapeutics, INC. | $30.31 | 2025 | Nexletol |
| Alnylam Pharmaceuticals INC. | $29.71 | 2023 | Onpattro |
| Recor Medical INC | $28.78 | 2025 | Paradise Ultrasound Renal Denervation System |
| Actelion Pharmaceuticals US, INC. | $27.13 | 2022 | |
| Vital Connect, INC | $21.56 | 2022 | |
| Endotronix, INC. | $21.46 | 2025 | Cordella Pulomonary Artery Pressure Sensor |
| Glaxosmithkline, LLC. | $15.74 | 2025 | Arexvy, Shingrix |
| Irhythm Technologies, INC. | $15.68 | 2019 | |
| Elutia, INC. | $14.03 | 2021 | |
| Medicure Pharma INC. | $11.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vinit Lal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.